Carlos Rodríguez‐Galindo

Author

St. Jude Children's Research Hospital ORCID

Also Known As

A Mariotto, B. G. Haik, C Galindo, C Rodrigue-ZGalindo, C Rodriguez-Galindo, C Rodriguez‐Galindo, C. Galindo, C. Rodriguez Galindo, C. Rodriguez-Galindo, C. Rodríguez-Galindo

737

Publications

27.3K

Citations

H-Index

183

Concepts

All Affiliations

St. Jude Children's Research Hospital University of Tennessee Health Science Center Dana-Farber Cancer Institute Harvard University Boston Children's Hospital

About

Carlos Rodríguez‐Galindo is an author at St. Jude Children's Research Hospital specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	35	71	4.6K
2	Health Sciences	14	15	1.1K
3	Education	2	2	49
4	Engineering	2	2	213
5	Nursing	2	2	40

Carlos Rodríguez‐Galindo

248

Publications

19K

Citations

H-Index

Page 1

	Year	Citations
Langerhans cell histiocytosis (LCH): Guidelines for diagnosis, clinical work‐up, and treatment for patients till the age of 18 years Riccardo Haupt, Milen Minkov, Itziar Astigarraga, Pediatric Blood & Cancer	2012	665
Inactivation of the p53 pathway in retinoblastoma Nikia A. Laurie, Stacy L. Donovan, Chie-Schin Shih, Nature Cell RegulationCell ProliferationTumor SuppressorP53 PathwayMedicine	2006	585
The Genomic Landscape of Pediatric Ewing Sarcoma Brian D. Crompton, Chip Stewart, Amaro Taylor‐Weiner, Cancer Discovery	2014	561
Clinical and Outcome Characteristics of Children With Adrenocortical Tumors: A Report From the International Pediatric Adrenocortical Tumor Registry Edson Michalkiewicz, R Sandrini, Bonald C. Figueiredo, Journal of Clinical Oncology	2004	512
Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma Jennifer A. Perry, Adam Kieżun, Peter Tonzi, Proceedings of the National Academy of Sciences	2014	484
Comparing Adult and Pediatric Rhabdomyosarcoma in the Surveillance, Epidemiology and End Results Program, 1973 to 2005: An Analysis of 2,600 Patients Iyad Sultan, Ibrahim Qaddoumi, Sameer Yaser, Journal of Clinical Oncology	2009	469
The global burden of childhood and adolescent cancer in 2017: an analysis of the Global Burden of Disease Study 2017 Lisa M Force, Ibrahim Abdollahpour, Shailesh M Advani, The Lancet Oncology	2019	378
Soft tissue sarcoma across the age spectrum: A population‐based study from the surveillance epidemiology and end results database Andrea Ferrari, Iyad Sultan, Tseng Tien Huang, Pediatric Blood & Cancer	2011	359
Patient-derived xenografts effectively capture responses to oncology therapy in a heterogeneous cohort of patients with solid tumors Eugene Izumchenko, K. Paz, Daniel Ciznadija, Annals of Oncology Heterogeneous CohortTumor BiologyPatient-derived XenograftsSolid TumorsMedicine	2017	332
Comparing children and adults with synovial sarcoma in the Surveillance, Epidemiology, and End Results program, 1983 to 2005 Iyad Sultan, Carlos Rodríguez‐Galindo, Raya Saab, Cancer	2009	326

Page 1